GBM: 1829 Clinical Trials, Page 1 of 183

1 2 3 4 5 10 15 20  Last Page »

Hide Studies Not Open or Pending


Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM

Condition(s):Astrocytoma, Grade IV; Giant Cell Glioblastoma; Glioblastoma Multiforme; Cyclophosphamide; Immunosuppressive Agents; Immunologic Factors; Physiological Effects of Drugs; Molecular Mechanisms of Pharmacological Action; Antiviral Agents; Anti-infective Agents; Analgesics, Non-narcotic; Analgesics; Sensory System Agents; Peripheral Nervous System AgentsLast Updated:July 14, 2021Active, not recruiting

1 2 3 4 5 10 15 20  Last Page »

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.